236 related articles for article (PubMed ID: 18358420)
1. Diabetes-related metabolic perturbations in cardiac myocyte.
Feuvray D; Darmellah A
Diabetes Metab; 2008 Feb; 34 Suppl 1():S3-9. PubMed ID: 18358420
[TBL] [Abstract][Full Text] [Related]
2. Diabetic cardiomyopathy.
Feuvray D
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):261-5. PubMed ID: 15106750
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
[TBL] [Abstract][Full Text] [Related]
4. [Modifications in myocardial energy metabolism in diabetic patients]].
Grynberg A
Diabetes Metab; 2001 Nov; 27(5 Pt 2):S12-9. PubMed ID: 11910980
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms.
Saunders J; Mathewkutty S; Drazner MH; McGuire DK
Herz; 2008 Apr; 33(3):184-90. PubMed ID: 18568312
[TBL] [Abstract][Full Text] [Related]
6. Metabolic toxicity of the heart: insights from molecular imaging.
Iozzo P
Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):147-56. PubMed ID: 20031381
[TBL] [Abstract][Full Text] [Related]
7. Glucose-insulin-potassium solution improves left ventricular energetics in chronic ovine diabetes.
Ramanathan T; Morita S; Huang Y; Shirota K; Nishimura T; Zheng X; Hunyor SN
Ann Thorac Surg; 2004 Apr; 77(4):1408-14. PubMed ID: 15063275
[TBL] [Abstract][Full Text] [Related]
8. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
9. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.
Severson DL
Can J Physiol Pharmacol; 2004 Oct; 82(10):813-23. PubMed ID: 15573141
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart.
Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G
Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288
[TBL] [Abstract][Full Text] [Related]
11. Genetic modification of the heart: transgenic modification of cardiac lipid and carbohydrate utilization.
Hartil K; Charron MJ
J Mol Cell Cardiol; 2005 Oct; 39(4):581-93. PubMed ID: 16140322
[TBL] [Abstract][Full Text] [Related]
12. Diabetic cardiomyopathy: a metabolic perspective.
Avogaro A; Vigili de Kreutzenberg S; Negut C; Tiengo A; Scognamiglio R
Am J Cardiol; 2004 Apr; 93(8A):13A-16A. PubMed ID: 15094099
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Gsalpha compensates for myocyte loss in diabetic cardiomyopathy.
Malhotra A; Kang BP; Vashistha H; Yadav VS; Meggs LG
Can J Physiol Pharmacol; 2008 Mar; 86(3):122-30. PubMed ID: 18418439
[TBL] [Abstract][Full Text] [Related]
15. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.
Kota SK; Kota SK; Jammula S; Panda S; Modi KD
Diabetes Technol Ther; 2011 Nov; 13(11):1155-60. PubMed ID: 21751873
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease.
Glyn-Jones S; Song S; Black MA; Phillips AR; Choong SY; Cooper GJ
Physiol Genomics; 2007 Feb; 28(3):284-93. PubMed ID: 17062650
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
[TBL] [Abstract][Full Text] [Related]
18. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species and insulin-resistant cardiomyopathy.
Mellor KM; Ritchie RH; Delbridge LM
Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):222-8. PubMed ID: 19671065
[TBL] [Abstract][Full Text] [Related]
20. Alterations in energy metabolism in cardiomyopathies.
Taha M; Lopaschuk GD
Ann Med; 2007; 39(8):594-607. PubMed ID: 17934906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
